SR-58894A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSR-58894A

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-3 adrenergic receptor antagonists

TargetsBeta-3 adrenergic receptor

Therapy Area/IndicationsGastrointestinal Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItalyFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi-Synthelabo

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi-Synthelabo

Active IndicationsN/A

Inactive IndicationsGastrointestinal Diseases

ATC CodeN/A